Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
No plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025 and Jan 2026.
- Largest single sale: $1.4M (49,800 shares) of Olema Pharmaceuticals, Inc. on Jan 13, 2026. Filing
- Last sale before this period: Dec 11, 2024.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | Ch. Discov. & Non-Clin Dev Off | Nov 18, 2020 | Feb 4, 2026 |
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jan 14, 2026, Olema Pharmaceuticals, Inc.: sold 50,000 shares for $1.4M, no plan disclosed; 50,000 shares acquired by exercising options. 1 filing: 1
- Jan 13, 2026, Olema Pharmaceuticals, Inc.: sold 50,000 shares for $1.4M, no plan disclosed; 50,000 shares acquired by exercising options. 1 filing: 1
- Jan 12, 2026, Olema Pharmaceuticals, Inc.: sold 10,000 shares for $283K, no plan disclosed (some held indirectly). 1 filing: 1
- Dec 19, 2025, Olema Pharmaceuticals, Inc.: sold 51,000 shares for $1.6M, no plan disclosed; 9,000 shares given away. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.